Congress tackles FDA cosmetics oversight
WASHINGTON (Reuters) - Democratic lawmakers seeking to bolster Food and Drug Administration oversight of imported products took aim at medical devices and cosmetics on Wednesday, saying the agency lacks the money and power to properly regulate them.
<p><img src="http://feeds.reuters.com/~a/reuters/healthNews?i=EPYE4y" border="0"></img> (http://feeds.reuters.com/~a/reuters/healthNews?a=EPYE4y)</p><div class="feedflare">
<img src="http://feeds.reuters.com/~f/reuters/healthNews?i=Uy94iH" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=Uy94iH) <img src="http://feeds.reuters.com/~f/reuters/healthNews?i=aVI5kh" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=aVI5kh) <img src="http://feeds.reuters.com/~f/reuters/healthNews?i=1TrF2h" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=1TrF2h)
</div><img src="http://feeds.reuters.com/~r/reuters/healthNews/~4/290506400" height="1" width="1"/>
http://feeds.reuters.com/~r/reuters/healthNews/~3/290506400/idUSN1452100220080514